Pharma BD Deal Intelligence

Hologic Inc. / Gen-Probe Incorporated

2012 · Acquisition/Merger · $3.8B · Complete

Announcement Sentiment

Strongly positive

Outcome Score

Worked — the deal delivered on its rationale.

Hologic acquired Gen-Probe for $82.75 per share in cash (approximately $3.7 billion announced, $3.8 billion net purchase price at close). The deal combined Hologic's women's health diagnostics with Gen-Probe's leading molecular diagnostics platforms (TIGRIS, PANTHER) and APTIMA STD testing franchise.

Key facts

Announced Apr 30, 2012
Closed Aug 01, 2012
Deal value $3.8B
Deal type Acquisition/Merger
Therapeutic area Infectious Disease, Oncology, Women's Health
Key assets TIGRIS automated platform, PANTHER automated platform, APTIMA STD test franchise, PROCLEIX blood screening products
Mechanism Nucleic acid amplification testing (NAAT), Transcription-mediated amplification (TMA)

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals